HIF1A and glioblastoma: Indeed, DCA treatment in glioblastoma cells targeted PDK2 and induced depolarization of mitochondria, apoptosis, inhibition of hypoxia-inducible factor 1-alpha (HIF1-α), activation of p53 and suppression of angiogenesis both in vitro and in vivo [70].